Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Current Editions
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
Company Profiles
Target Profiles
Product Profiles
Free Trial Information
Export Pdf
Overview
Pipeline
Deals
Financings
Earnings Summary
Stock Summary
Articles
BioCentury
|
Jun 13, 2019
Emerging Company Profile
Gracell: Speeding up CAR T cells
...NA Number of employees: 90 Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Mar 2, 2019
Company News
Emerging company roundup: Anthos, Maze, Oyster Point
...$85 million B round for Gracell Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Feb 28, 2019
Financial News
Gracell raises $85M series B to advance cell therapies
...therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China) that closed Feb. 25. Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Feb 25, 2019
Financial News
Gracell raises $85M series B to advance cell therapies
...B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Aug 31, 2018
Financial News
Harbin Gloria selling stake in biotech unit to new investors
...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou
Kington Capital
...
Read More
BioCentury
|
Aug 17, 2018
Financial News
Harbin Gloria selling stake in biotech unit
...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou
Kington Capital
...
Read More
Items per page:
10
1 - 6 of 6
BioCentury
|
Jun 13, 2019
Emerging Company Profile
Gracell: Speeding up CAR T cells
...NA Number of employees: 90 Funds raised: About $100 million Investors: Temasek, Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Mar 2, 2019
Company News
Emerging company roundup: Anthos, Maze, Oyster Point
...$85 million B round for Gracell Biotechnologies Co. Ltd. (Suzhou, China) Monday. Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Feb 28, 2019
Financial News
Gracell raises $85M series B to advance cell therapies
...therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China) that closed Feb. 25. Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Feb 25, 2019
Financial News
Gracell raises $85M series B to advance cell therapies
...B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures,
Kington Capital
...
Read More
BioCentury
|
Aug 31, 2018
Financial News
Harbin Gloria selling stake in biotech unit to new investors
...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou
Kington Capital
...
Read More
BioCentury
|
Aug 17, 2018
Financial News
Harbin Gloria selling stake in biotech unit
...investors. The investors, which also include Suzhou Tonghe Phase II Venture Capital Partnership and Suzhou
Kington Capital
...
Read More
Items per page:
10
1 - 6 of 6
Previous page
Next page